Axiom Investors LLC Ardelyx, Inc. Transaction History

Axiom Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$3.7 - $5.8 $714,773 - $1.12 Million	-193,182 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$5.05 - $7.9 $95,950 - $150,100	-19,000 Reduced 8.95%	193,182 $976,000
Q4 2017 Feb 14, 2018	BUY	$4.85 - $7.8 $140,431 - $225,849	28,955 Added 15.8%	212,182 $1.4 Million
Q3 2017 Nov 09, 2017	BUY	$4.35 - $5.7 $315,692 - $413,666	72,573 Added 65.59%	183,227 $1.03 Million
Q2 2017 Aug 14, 2017	BUY	N/A	110,654	110,654 $564,000

209

144M

1.01M

1.43M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $994M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.